Effect of Gender Affirming Hormone Therapy on Glucose Metabolism
Condition:   Transgender Persons Interventions:   Drug: Botnia Clamp;   Other: Withdrawal of Gender Affirming Hormone Therapy (GAHT) Sponsors:   The University of Texas Health Science Center at San Antonio;   Foundation for advancing Veterans Health Research (FAVHR) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2020 Category: Research Source Type: clinical trials

Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study
Condition:   Prostate Carcinoma Interventions:   Drug: Darolutamide;   Drug: Goserelin Acetate;   Drug: Leuprolide Acetate;   Drug: Placebo Administration;   Other: Quality-of-Life Assessment;   Drug: Triptorelin Sponsors:   ECOG-ACRIN Cancer Research Group;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 24, 2020 Category: Research Source Type: clinical trials

Effect of Hormone Therapy on Renal Function
Conditions:   Transgenderism;   Kidney Diseases;   Kidney Injury Interventions:   Diagnostic Test: p-aminohippurate clearance study;   Diagnostic Test: Iohexol infusion Sponsor:   University of Colorado, Denver Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2020 Category: Research Source Type: clinical trials

Trans & Non-binary Reference Intervals While on Hormone Therapy Study
Conditions:   Transgender Persons;   Hormone Replacement Therapy;   Reference Values Intervention:   Sponsor:   King's College Hospital NHS Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2020 Category: Research Source Type: clinical trials